Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-26 @ 3:54 AM
Study NCT ID:
NCT05791318
Status:
COMPLETED
Last Update Posted:
2024-05-31
First Post:
2023-03-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants
Sponsor:
Invivyd, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-16
First Submit QC Date:
None
Study First Post Date:
2023-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-30
Last Update Post Date:
2024-05-31
Last Update Post Date Type:
ACTUAL